TY - JOUR
T1 - Capillary-Assisted Molecular Pendulum Bioanalysis
AU - Zargartalebi, Hossein
AU - Yousefi, Hanie
AU - Flynn, Connor D.
AU - Gomis, Surath
AU - Das, Jagotamoy
AU - Young, Tiana L.
AU - Chien, Emily
AU - Mubareka, Samira
AU - McGeer, Allison
AU - Wang, Hansen
AU - Sargent, Edward H.
AU - Nezhad, Amir Sanati
AU - Kelley, Shana O.
N1 - Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/10/12
Y1 - 2022/10/12
N2 - The development of robust biosensing strategies that can be easily implemented in everyday life remains a challenge for the future of modern biosensor research. While several reagentless approaches have attempted to address this challenge, they often achieve user-friendliness through sacrificing sensitivity or universality. While acceptable for certain applications, these trade-offs hinder the widespread adoption of reagentless biosensing technologies. Here, we report a novel approach to reagentless biosensing that achieves high sensitivity, rapid detection, and universality using the SARS-CoV-2 virus as a model target. Universality is achieved by using nanoscale molecular pendulums, which enables reagentless electrochemical biosensing through a variable antibody recognition element. Enhanced sensitivity and rapid detection are accomplished by incorporating the coffee-ring phenomenon into the sensing scheme, allowing for target preconcentration on a ring-shaped electrode. Using this approach, we obtained limits of detection of 1 fg/mL and 20 copies/mL for the SARS-CoV-2 nucleoproteins and viral particles, respectively. In addition, clinical sample analysis showed excellent agreement with Ct values from PCR-positive SARS-CoV-2 patients.
AB - The development of robust biosensing strategies that can be easily implemented in everyday life remains a challenge for the future of modern biosensor research. While several reagentless approaches have attempted to address this challenge, they often achieve user-friendliness through sacrificing sensitivity or universality. While acceptable for certain applications, these trade-offs hinder the widespread adoption of reagentless biosensing technologies. Here, we report a novel approach to reagentless biosensing that achieves high sensitivity, rapid detection, and universality using the SARS-CoV-2 virus as a model target. Universality is achieved by using nanoscale molecular pendulums, which enables reagentless electrochemical biosensing through a variable antibody recognition element. Enhanced sensitivity and rapid detection are accomplished by incorporating the coffee-ring phenomenon into the sensing scheme, allowing for target preconcentration on a ring-shaped electrode. Using this approach, we obtained limits of detection of 1 fg/mL and 20 copies/mL for the SARS-CoV-2 nucleoproteins and viral particles, respectively. In addition, clinical sample analysis showed excellent agreement with Ct values from PCR-positive SARS-CoV-2 patients.
UR - http://www.scopus.com/inward/record.url?scp=85139279442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139279442&partnerID=8YFLogxK
U2 - 10.1021/jacs.2c06192
DO - 10.1021/jacs.2c06192
M3 - Article
C2 - 36173381
AN - SCOPUS:85139279442
SN - 0002-7863
VL - 144
SP - 18338
EP - 18349
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 40
ER -